Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification

NCT03380052 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT03380052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03380052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification
Lead sponsor
Seoul National University Bundang Hospital
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
January 31, 2022
Enrollment
2,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, intestinal metaplasia, stomach neoplasms